Philips Electronics North America Corp.

Philips Electronics North America Corp. (now registered as Philips North America LLC, commonly "Philips North America") is a Delaware corporation incorporated August 6, 1987, and the principal U.S. operating and holding subsidiary of Koninklijke Philips N.V. ("Royal Philips") of Amsterdam, which is publicly listed (NYSE: PHG; Euronext Amsterdam: PHIA) and wholly owns it. Its legacy headquarters was 3000 Minuteman Road, Andover, Massachusetts; recent court filings list its principal place of business at 222 Jacobs Street, Cambridge, Massachusetts. Royal Philips reported 2024 sales of EUR 18.0 billion and roughly 67,800 employees globally (Philips Q4/FY2024 results, Feb. 19, 2025).

Operations. This is an operating company, not an NPE. It houses Philips' North American businesses, historically spanning consumer electronics, lighting, televisions (Magnavox, Norelco, Sylvania) and CRT products, and today centered on health technology: diagnostic imaging, patient monitoring and connected care, sleep and respiratory care (Philips Respironics, now Philips RS North America), emergency care/defibrillators, and personal health products such as Sonicare oral care and shavers. Its SEC/state filings describe the business simply as "manufacture and sale of electronic products."

Litigation posture. The tracked data show exactly one case, and the company appears solely as a defendant — consistent with an operating company being targeted rather than a serial filer. Cedar Lane Technologies Inc., a Canadian patent-assertion entity (characterized as an NPE by Unified Patents and Stanford's NPE database, asserting patents acquired largely from Intellectual Ventures), sued it in the District of Delaware on August 25, 2021, asserting U.S. Patent 8,165,867, "Methods for translating a device command." Delaware, like the Eastern District of Texas, is a favored NPE venue; Philips is incorporated there.

Case outcome. Cedar Lane's suit (No. 1:21-cv-01208, Judge Richard G. Andrews) was voluntarily dismissed by the plaintiff on September 7, 2021, roughly two weeks after filing — typical of Cedar Lane's high-volume, fast-settling campaign. Philips itself is a substantial patent holder and has separately asserted portfolio patents (for example, CPAP-related ITC and Delaware actions), but no plaintiff-side cases appear in this dataset.